Home Nephro Research The current and future landscape of dialysis

The current and future landscape of dialysis

Credits to the Source Link Obum
The current and future landscape of dialysis
  • 1.

    Peitzman, S. J. Chronic dialysis and dialysis doctors in the United States: a nephrologist-historian’s perspective. Semin. Dial. 14, 200–208 (2001).

    CAS 
    PubMed 

    Google Scholar
     

  • 2.

    Brescia, M. J., Cimino, J. E., Appel, K. & Hurwich, B. J. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N. Engl. J. Med. 275, 1089–1092 (1966).

    CAS 
    PubMed 

    Google Scholar
     

  • 3.

    Blagg, C. R. The early history of dialysis for chronic renal failure in the United States: a view from Seattle. Am. J. Kidney Dis. 49, 482–496 (2007).

    PubMed 

    Google Scholar
     

  • 4.

    Scribner, B. H. Ethical problems of using artificial organs to sustain human life. Trans. Am. Soc. Artif. Intern. Organs 10, 209–212 (1964).

    CAS 
    PubMed 

    Google Scholar
     

  • 5.

    Blagg, D. C. R. From Miracle to Mainstream: Creating the World’s First Dialysis Organization (Northwest Kidney Centers, 2017).

  • 6.

    Himmelfarb, J., Berns, A., Szczech, L. & Wesson, D. Cost, quality, and value: the changing political economy of dialysis care. J. Am. Soc. Nephrol. 18, 2021–2027 (2007).

    PubMed 

    Google Scholar
     

  • 7.

    KDIGO. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 163 (2013).


    Google Scholar
     

  • 8.

    Hole, B. et al. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. Kidney Int. Suppl. 10, e86–e94 (2020).


    Google Scholar
     

  • 9.

    Bikbov, B. et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020).


    Google Scholar
     

  • 10.

    Liyanage, T. et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385, 1975–1982 (2015).

    PubMed 

    Google Scholar
     

  • 11.

    Tonelli, M. et al. Framework for establishing integrated kidney care programs in low- and middle-income countries. Kidney Int. Suppl. 10, e19–e23 (2020).


    Google Scholar
     

  • 12.

    Pecoits-Filho, R. et al. Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. Kidney Int. Suppl. 10, e3–e9 (2020).


    Google Scholar
     

  • 13.

    Bello A. K. L. et al. Global Kidney Health Atlas: a report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. https://www.kidneycareuk.org/documents/52/ISN_Global_kidney_health_atlas.pdf (2017).

  • 14.

    White, S. et al. How can we achieve global equity in provision of renal replacement therapy? Bull. World Health Organ. 86, 229–237 (2008).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 15.

    Bello, A. K. et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ 367, l5873 (2019).

    PubMed 

    Google Scholar
     

  • 16.

    Luxardo, R. et al. The epidemiology of renal replacement therapy in two different parts of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Association-European Dialysis and Transplant Association Registry. Rev. Panam. Salud Publica 42, e87 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 17.

    United States Renal Data System. Volume 2: ESRD in the United States https://www.usrds.org/2018/download/2018_Volume_2_ESRD_in_the_US.pdf (2018).

  • 18.

    Jha, V. et al. The state of nephrology in South Asia. Kidney Int. 95, 31–37 (2019).

    PubMed 

    Google Scholar
     

  • 19.

    Barsoum, R. S., Khalil, S. S. & Arogundade, F. A. Fifty years of dialysis in Africa: challenges and progress. Am. J. Kidney Dis. 65, 502–512 (2015).

    PubMed 

    Google Scholar
     

  • 20.

    Bello, A. K. et al. Assessment of Global Kidney Health Care Status. JAMA 317, 1864–1881 (2017).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 21.

    Fresenius Medical Care. Annual Report 2018: Care and Live. https://www.freseniusmedicalcare.com/fileadmin/data/com/pdf/Media_Center/Publications/Annual_Reports/FME_Annual-Report_2018.pdf (2018).

  • 22.

    United States Renal Data System. US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States. https://www.usrds.org/2019/view/USRDS_2019_ES_final.pdf (2019).

  • 23.

    Liu, F. X. et al. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit. Dial. Int. 35, 406–420 (2015).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 24.

    Mehrotra, R. et al. Racial and ethnic disparities in use of and outcomes with home dialysis in the United States. J. Am. Soc. Nephrol. 27, 2123–2134 (2016).

    PubMed 

    Google Scholar
     

  • 25.

    Li, P. K.-T. et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat. Rev. Nephrol. 13, 90–103 (2017).

    CAS 
    PubMed 

    Google Scholar
     

  • 26.

    ANZDATA Registry. ANZDATA 42nd Annual Report 2019. https://www.anzdata.org.au/report/anzdata-42nd-annual-report-2019/ (2019).

  • 27.

    Kramer, A. et al. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry annual report 2015: a summary. Clin. Kidney J. 11, 108–122 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 28.

    Anand, S., Bitton, A. & Gaziano, T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS ONE 8, e72860 (2013).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 29.

    Modi, G. K. & Jha, V. The incidence of end-stage renal disease in India: a population-based study. Kidney Int. 70, 2131–2133 (2006).

    CAS 
    PubMed 

    Google Scholar
     

  • 30.

    Robinson, B. M. et al. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet 388, 294–306 (2016).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 31.

    Antlanger, M. et al. Sex differences in kidney replacement therapy initiation and maintenance. Clin. J. Am. Soc. Nephrol. 14, 1616 (2019).

    PubMed 

    Google Scholar
     

  • 32.

    Chan, K. E. et al. Early outcomes among those initiating chronic dialysis in the United States. Clin. J. Am. Soc. Nephro 6, 2642–2649 (2011).

    CAS 

    Google Scholar
     

  • 33.

    Thamer, M. et al. Predicting early death among elderly dialysis patients: development and validation of a risk score to assist shared decision making for dialysis initiation. Am. J. Kidney Dis. 66, 1024–1032 (2015).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 34.

    Garcia-Garcia, G. et al. Survival among patients with kidney failure in Jalisco, Mexico. J. Am. Soc. Nephrol. 18, 1922–1927 (2007).

    PubMed 

    Google Scholar
     

  • 35.

    Foster, B. J., Mitsnefes, M. M., Dahhou, M., Zhang, X. & Laskin, B. L. Changes in excess mortality from end stage renal disease in the United States from 1995 to 2013. Clin. J. Am. Soc. Nephrol. 13, 91–99 (2018).

    PubMed 

    Google Scholar
     

  • 36.

    Storey, B. C. et al. Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy. Kidney Int. 93, 1165–1174 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 37.

    Fenton, S. S. et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am. J. Kidney Dis. 30, 334–342 (1997).

    CAS 
    PubMed 

    Google Scholar
     

  • 38.

    Vonesh, E. F., Snyder, J. J., Foley, R. N. & Collins, A. J. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 66, 2389–2401 (2004).

    PubMed 

    Google Scholar
     

  • 39.

    Mehrotra, R., Chiu, Y. W., Kalantar-Zadeh, K., Bargman, J. & Vonesh, E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch. Intern. Med. 171, 110–118 (2011).

    PubMed 

    Google Scholar
     

  • 40.

    Mehrotra, R., Devuyst, O., Davies, S. J. & Johnson, D. W. The current state of peritoneal dialysis. J. Am. Soc. Nephrol. 27, 3238–3252 (2016).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 41.

    Mehrotra, R. et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J. Am. Soc. Nephrol. 18, 2781–2788 (2007).

    PubMed 

    Google Scholar
     

  • 42.

    Modi, Z. J. et al. Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: an analysis of the us renal data system. JAMA Cardiol. 4, 353–362 (2019).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 43.

    Wetmore, J. B. et al. Insights from the 2016 peer kidney care initiative report: still a ways to go to improve care for dialysis patients. Am. J. Kidney Dis. 71, 123–132 (2018).

    PubMed 

    Google Scholar
     

  • 44.

    Skov Dalgaard, L. et al. Risk and prognosis of bloodstream infections among patients on chronic hemodialysis: a population-based cohort study. PLoS One 10, e0124547 (2015).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 45.

    Nelveg-Kristensen, K. E., Laier, G. H. & Heaf, J. G. Risk of death after first-time blood stream infection in incident dialysis patients with specific consideration on vascular access and comorbidity. BMC Infect. Dis. 18, 688 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 46.

    Chaudry, M. S. et al. Risk of infective endocarditis in patients with end stage renal disease. Clin. J. Am. Soc. Nephrol. 12, 1814–1822 (2017).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 47.

    Pruthi, R., Steenkamp, R. & Feest, T. UK renal registry 16th annual report: chapter 8 survival and cause of death of UK adult patients on renal replacement therapy in 2012: national and centre-specific analyses. Nephron. Clin. Pract. 125, 139–169 (2013).

    PubMed 

    Google Scholar
     

  • 48.

    Kucirka, L. M. et al. Association of race and age with survival among patients undergoing dialysis. JAMA 306, 620–626 (2011).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 49.

    van den Beukel, T. O. et al. The role of psychosocial factors in ethnic differences in survival on dialysis in The Netherlands. Nephrol. Dial. Transpl. 27, 2472–2479 (2012).


    Google Scholar
     

  • 50.

    Depner, T. et al. Dialysis dose and the effect of gender and body size on outcome in the HEMO study. Kidney Ing. 65, 1386–1394 (2004).


    Google Scholar
     

  • 51.

    Villar, E., Remontet, L., Labeeuw, M. & Ecochard, R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J. Am. Soc. Nephrol. 18, 2125–2134 (2007).

    PubMed 

    Google Scholar
     

  • 52.

    Hecking, M. et al. Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the dialysis outcomes and practice patterns study (DOPPS). PLoS Med. 11, e1001750 (2014).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 53.

    Erickson, K. F., Zhao, B., Ho, V. & Winkelmayer, W. C. Employment among patients starting dialysis in the United States. Clin. J. Am. Soc. Nephrol. 13, 265–273 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 54.

    Kurella Tamura, M. et al. Functional status of elderly adults before and after initiation of dialysis. N. Eng. J. Med. 361, 1539–1547 (2009).


    Google Scholar
     

  • 55.

    Daratha, K. B. et al. Risks of subsequent hospitalization and death in patients with kidney disease. Clin. J. Am. Soc. Nephrol. 7, 409–416 (2012).

    PubMed 

    Google Scholar
     

  • 56.

    Davison, S. N. & Jhangri, G. S. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J. Pain. Symptom Manage. 39, 477–485 (2010).

    PubMed 

    Google Scholar
     

  • 57.

    Eneanya, N. D. et al. Longitudinal patterns of health-related quality of life and dialysis modality: a national cohort study. BMC Nephrol. 20, 7 (2019).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 58.

    Ju, A. et al. Patient-reported outcome measures for fatigue in patients on hemodialysis: a systematic review. Am. J. Kidney Dis. 71, 327–343 (2018).

    PubMed 

    Google Scholar
     

  • 59.

    Rhee, E. P. et al. Prevalence and persistence of uremic symptoms in incident dialysis patients. Kidney360 1, 86–92 (2020).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 60.

    Kimmel, P. L. & Peterson, R. A. Depression in patients with end-stage renal disease treated with dialysis: has the time to treat arrived? Clin. J. Am. Soc. Nephrol. 1, 349–352 (2006).

    PubMed 

    Google Scholar
     

  • 61.

    Burnier, M., Pruijm, M., Wuerzner, G. & Santschi, V. Drug adherence in chronic kidney diseases and dialysis. Nephrol. Dial. Transpl. 30, 39–44 (2015).

    CAS 

    Google Scholar
     

  • 62.

    Viecelli, A. K. et al. Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals. Nephrol. Dial. Transpl. 35, 657–668 (2020).


    Google Scholar
     

  • 63.

    Ceretta, M. L. et al. Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA registry. Nephrol. Dial. Transpl. 33, 1794–1804 (2018).

    CAS 

    Google Scholar
     

  • 64.

    Vanholder, R. et al. Reimbursement of dialysis: a comparison of seven countries. J. Am. Soc. Nephrol. 23, 1291–1298 (2012).

    PubMed 

    Google Scholar
     

  • 65.

    Winkelmayer, W. C., Weinstein, M. C., Mittleman, M. A., Glynn, R. J. & Pliskin, J. S. Health economic evaluations: the special case of end-stage renal disease treatment. Med. Decis. Mak. 22, 417–430 (2002).


    Google Scholar
     

  • 66.

    Vanholder, R. et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat. Rev. Nephrol. 13, 393–409 (2017).

    PubMed 

    Google Scholar
     

  • 67.

    Klarenbach, S. & Manns, B. Economic evaluation of dialysis therapies. Semin. Nephrol. 29, 524–532 (2009).

    PubMed 

    Google Scholar
     

  • 68.

    van der Tol, A., Lameire, N., Morton, R. L., Van Biesen, W. & Vanholder, R. An international analysis of dialysis services reimbursement. Clin. J. Am. Soc. Nephrol. 14, 84–93 (2019).

    PubMed 

    Google Scholar
     

  • 69.

    Beaudry, A. et al. Cost of dialysis therapy by modality in Manitoba. Clin. J. Am. Soc. Nephrol. 13, 1197–1203 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 70.

    Golper, T. A. The possible impact of the US prospective payment system (“bundle”) on the growth of peritoneal dialysis. Perit. Dial. Int. 33, 596–599 (2013).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 71.

    Lin, E. et al. Home dialysis in the prospective payment system era. J. Am. Soc. Nephrol. 28, 2993–3004 (2017).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 72.

    Shen, J. I. et al. Expanded prospective payment system and use of and outcomes with home dialysis by race and ethnicity in the United States. Clin. J. Am. Soc. Nephrol. 14, 1200–1212 (2019).

    PubMed 

    Google Scholar
     

  • 73.

    Wang, V. et al. Medicare’s new prospective payment system on facility provision of peritoneal dialysis. Clin. J. Am. Soc. Nephrol. 13, 1833–1841 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 74.

    Swanepoel, C. R., Wearne, N. & Okpechi, I. G. Nephrology in Africa–not yet uhuru. Nat. Rev. Nephrol. 9, 610–622 (2013).

    PubMed 

    Google Scholar
     

  • 75.

    Wang, V., Vilme, H., Maciejewski, M. L. & Boulware, L. E. The economic burden of chronic kidney disease and end-stage renal disease. Semin. Nephrol. 36, 319–330 (2016).

    PubMed 

    Google Scholar
     

  • 76.

    Martin, D. E. et al. A call for professional collaboration to address ethical challenges in nephrology. Nat Rev Nephrol. https://doi.org/10.1038/s41581-020-0295-4 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • 77.

    Harris, D. C. H. et al. Increasing access to integrated ESKD care as part of universal health coverage. Kidney Int. 95, S1–S33 (2019).

    PubMed 

    Google Scholar
     

  • 78.

    Rodriguez, R. A. Dialysis for undocumented immigrants in the United States. Adv. Chronic Kidney Dis. 22, 60–65 (2015).

    PubMed 

    Google Scholar
     

  • 79.

    Saunders, M. R., Lee, H., Maene, C., Schuble, T. & Cagney, K. A. Proximity does not equal access: racial disparities in access to high quality dialysis facilities. J. Racial Ethn. Health Disparities 1, 291–299 (2014).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 80.

    Shaikh, M. et al. Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India. Kidney Int. 94, 440–445 (2018).

    PubMed 

    Google Scholar
     

  • 81.

    Ladin, K. & Smith, A. K. Active medical management for patients with advanced kidney disease. JAMA Intern. Med. 179, 313–315 (2019).

    PubMed 

    Google Scholar
     

  • 82.

    Boulware, L. E., Wang, V. & Powe, N. R. Improving access to kidney transplantation: business as usual or new ways of doing business? JAMA 322, 931–933 (2019).

    PubMed 

    Google Scholar
     

  • 83.

    Van Biesen, W., van der Veer, S. N., Murphey, M., Loblova, O. & Davies, S. Patients’ perceptions of information and education for renal replacement therapy: an independent survey by the European Kidney Patients’ Federation on information and support on renal replacement therapy. PLoS ONE 9, e103914 (2014).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 84.

    Mehrotra, R., Marsh, D., Vonesh, E., Peters, V. & Nissenson, A. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int. 68, 378–390 (2005).

    PubMed 

    Google Scholar
     

  • 85.

    Taylor, D. M. et al. A systematic review of the prevalence and associations of limited health literacy in CKD. Clin. J. Am. Soc. Nephrol. 12, 1070–1084 (2017).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 86.

    Vanholder, R., Van Biesen, W. & Lameire, N. Renal replacement therapy: how can we contain the costs? Lancet 383, 1783–1785 (2014).

    PubMed 

    Google Scholar
     

  • 87.

    Moss, A. H. Revised dialysis clinical practice guideline promotes more informed decision-making. Clin. J. Am. Soc. Nephrol. 5, 2380–2383 (2010).

    PubMed 

    Google Scholar
     

  • 88.

    Williams, A. W. et al. Critical and honest conversations: the evidence behind the “Choosing Wisely” campaign recommendations by the American Society of Nephrology. Clin. J. Am. Soc. Nephrol. 7, 1664–1672 (2012).

    PubMed 

    Google Scholar
     

  • 89.

    Rinehart, A. Beyond the futility argument: the fair process approach and time-limited trials for managing dialysis conflict. Clin. J. Am. Soc. Nephrol. 8, 2000–2006 (2013).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 90.

    Ladin, K. et al. Characterizing approaches to dialysis decision making with older adults: a qualitative study of nephrologists. Clin. J. Am. Soc. Nephrol. 13, 1188–1196 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 91.

    Luyckx, V. A. et al. Developing the ethical framework of end-stage kidney disease care: from practice to policy. Kidney Int. Suppl. 10, e72–e77 (2020).


    Google Scholar
     

  • 92.

    Davison, S. N., Jhangri, G. S. & Johnson, J. A. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int. 69, 1621–1625 (2006).

    CAS 
    PubMed 

    Google Scholar
     

  • 93.

    Weisbord, S. D. et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin. J. Am. Soc. Nephrol. 2, 960–967 (2007).

    PubMed 

    Google Scholar
     

  • 94.

    Eknoyan, G. et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347, 2010–2019 (2002).

    PubMed 

    Google Scholar
     

  • 95.

    Paniagua, R. et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J. Am. Soc. Nephrol. 13, 1307–1320 (2002).

    CAS 
    PubMed 

    Google Scholar
     

  • 96.

    Locatelli, F. et al. Effect of membrane permeability on survival of hemodialysis patients. J. Am. Soc. Nephrol. 20, 645–654 (2009).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 97.

    Group, F. H. N. T. et al. In-center hemodialysis six times per week versus three times per week. N. Engl. J. Med. 363, 2287–2300 (2010).


    Google Scholar
     

  • 98.

    Rocco, M. V. et al. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int. 80, 1080–1091 (2011).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 99.

    Grooteman, M. P. C. et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J. Am. Soc. Nephrol. 23, 1087 (2012).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 100.

    Farrington, K. & Davenport, A. The ESHOL study: hemodiafiltration improves survival – but how? Kidney Int. 83, 979–981 (2013).

    PubMed 

    Google Scholar
     

  • 101.

    Maduell, F. et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J. Am. Soc. Nephrol. 24, 487 (2013).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 102.

    Besarab, A. et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N. Engl. J. Med. 339, 584–590 (1998).

    CAS 
    PubMed 

    Google Scholar
     

  • 103.

    Suki, W. N. et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 72, 1130–1137 (2007).

    CAS 
    PubMed 

    Google Scholar
     

  • 104.

    Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238–248 (2005).

    CAS 
    PubMed 

    Google Scholar
     

  • 105.

    Fellstrom, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395–1407 (2009).

    CAS 
    PubMed 

    Google Scholar
     

  • 106.

    Baigent, C. et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377, 2181–2192 (2011).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 107.

    Abdel-Kader, K., Unruh, M. L. & Weisbord, S. D. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin. J. Am. Soc. Nephrol. 4, 1057–1064 (2009).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 108.

    Mehrotra, R., Berman, N., Alistwani, A. & Kopple, J. D. Improvement of nutritional status after initiation of maintenance hemodialysis. Am. J. Kidney Dis. 40, 133–142 (2002).

    PubMed 

    Google Scholar
     

  • 109.

    Pupim, L. B. et al. Improvement in nutritional parameters after initiation of chronic hemodialysis. Am. J. Kidney Dis. 40, 143–151 (2002).

    PubMed 

    Google Scholar
     

  • 110.

    Rivara, M. B. et al. Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic kidney disease. Hemodial. Int. 19, 147–150 (2015).

    PubMed 

    Google Scholar
     

  • 111.

    Flythe, J. E. et al. Symptom prioritization among adults receiving in-center hemodialysis: a mixed methods study. Clin. J. Am. Soc. Nephrol. 13, 735–745 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 112.

    Tong, A. et al. Establishing core outcome domains in hemodialysis: report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop. Am. J. Kidney Dis. 69, 97–107 (2017).

    PubMed 

    Google Scholar
     

  • 113.

    Evangelidis, N. et al. Developing a set of core outcomes for trials in hemodialysis: an international Delphi survey. Am. J. Kidney Dis. 70, 464–475 (2017).

    PubMed 

    Google Scholar
     

  • 114.

    Urquhart-Secord, R. et al. Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am. J. Kidney Dis. 68, 444–454 (2016).

    PubMed 

    Google Scholar
     

  • 115.

    Manera, K. E. et al. Patient and caregiver priorities for outcomes in peritoneal dialysis: multinational nominal group technique study. Clin. J. Am. Soc. Nephrol. 14, 74–83 (2019).

    PubMed 

    Google Scholar
     

  • 116.

    Manera, K. E. et al. An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis. Kidney Int. 96, 699–710 (2019).

    PubMed 

    Google Scholar
     

  • 117.

    Duarte, P. S., Miyazaki, M. C., Blay, S. L. & Sesso, R. Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int. 76, 414–421 (2009).

    PubMed 

    Google Scholar
     

  • 118.

    Taraz, M. et al. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. Int. Immunopharmacol. 17, 917–923 (2013).

    CAS 
    PubMed 

    Google Scholar
     

  • 119.

    Cukor, D. et al. Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J. Am. Soc. Nephrol. 25, 196–206 (2014).

    CAS 
    PubMed 

    Google Scholar
     

  • 120.

    Friedli, K. et al. Sertraline versus placebo in patients with major depressive disorder undergoing hemodialysis: a randomized, controlled feasibility trial. Clin. J. Am. Soc. Nephrol. 12, 280–286 (2017).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 121.

    Mehrotra, R. et al. Comparative efficacy of therapies for treatment of depression for patients undergoing maintenance hemodialysis: a randomized clinical trial. Ann. Intern. Med. 170, 369–379 (2019).

    PubMed 

    Google Scholar
     

  • 122.

    Mendu, M. L. et al. Measuring quality in kidney care: an evaluation of existing quality metrics and approach to facilitating improvements in care delivery. J. Am. Soc. Nephrol. 31, 602–614 (2020).

    PubMed 

    Google Scholar
     

  • 123.

    Nair, D. & Wilson, F. P. Patient-reported outcome measures for adults with kidney disease: current measures, ongoing initiatives, and future opportunities for incorporation into patient-centered kidney care. Am. J. Kidney Dis. 74, 791–802 (2019).

    PubMed 

    Google Scholar
     

  • 124.

    Himmelfarb, J. & Ratner, B. Wearable artificial kidney: problems, progress and prospects. Nat. Rev. Nephrol. in press [doi to be supplied]

  • 125.

    Foo, M. W. Y. & Htay, H. Innovations in peritoneal dialysis. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0283-8 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • 126.

    Agar, J. W. M. & Barraclough, K. A. Water use in dialysis: environmental considerations. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0296-3 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • 127.

    Masereeuw, R. & Verhaar, M. C. Innovations in approaches to remove uraemic toxins. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0299-0 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • 128.

    Geremia, I. & Stamatialis, D. Innovations in dialysis membranes for improved kidney replacement therapy. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0293-6 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • 129.

    Gedney, N., Sipma, W. & Søndergaard, H. Innovations in dialysis: the user’s perspective. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0292-7 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • 130.

    Wieringa, F. P., Sheldon, M. I. & Hidalgo-Simon, A. Regulatory approaches to stimulate innovative renal replacement therapies. Nat. Rev. Nephrol. https://doi.org/10.1038/s41581-020-0275-8 (2020).

    Article 
    PubMed 

    Google Scholar
     

  • 131.

    Kidney Health Initiatve. Fostering Innovation in Fluid Management. https://khi.asn-online.org/uploads/KHI_InnovationsInFluidManagement.pdf (2019).

  • 132.

    Flythe, J. E. et al. Fostering innovation in symptom management among hemodialysis patients. Clin. J. Am. Soc. Nephrol. 14, 150 (2019).

    PubMed 

    Google Scholar
     

  • 133.

    Shenoy, S. et al. Clinical trial end points for hemodialysis vascular access. Clin. J. Am. Soc. Nephrol. 13, 490 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 134.

    Dember, L. M. et al. Pragmatic trials in maintenance dialysis: perspectives from the kidney health initiative. J. Am. Soc. Nephrol. 27, 2955 (2016).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 135.

    Canaud, B., Vienken, J., Ash, S. & Ward, R. A. Hemodiafiltration to address unmet medical needs ESKD patients. Clin. J. Am. Soc. Nephrol. 13, 1435 (2018).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 136.

    Trump, D. J. Executive Order on Advancing American Kidney Health. The White House https://www.whitehouse.gov/presidential-actions/executive-order-advancing-american-kidney-health/ (2019).

  • 137.

    Kidney Health Initiative. Technology Roadmap for Innovative Approaches to Renal Replacement Therapy. https://www.asn-online.org/g/blast/files/KHI_RRT_Roadmap1.0_FINAL_102318_web.pdf (2018).

  • 138.

    Tijink, M. S. L. et al. Mixed matrix membranes: a new asset for blood purification therapies. Blood Purif. 37, 1–3 (2014).

    CAS 
    PubMed 

    Google Scholar
     

  • 139.

    Vijayan, A. & Boyce, J. M. 100% use of infection control procedures in hemodialysis facilities: call to action. Clin. J. Am. Soc. Nephrol. 13, 671–673 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 140.

    Wong, L. P. Achieving dialysis safety: the critical role of higher-functioning teams. Semin. Dial. 32, 266–273 (2019).

    PubMed 

    Google Scholar
     

  • 141.

    Kliger, A. S. & Collins, A. J. Long overdue need to reduce infections with hemodialysis. Clin. J. Am. Soc. Nephrol. 12, 1728–1729 (2017).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 142.

    Kliger, A. S. Targeting zero infections in dialysis: new devices, yes, but also guidelines, checklists, and a culture of safety. J. Am. Soc. Nephrol. 29, 1083–1084 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 143.

    Collins, A. J. & Kliger, A. S. Urgent: stop preventable infections now. Clin. J. Am. Soc. Nephrol. 13, 663–665 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 144.

    The George Institute. World’s first affordable dialysis machine a finalist in 2017 Eureka Awards. https://www.georgeinstitute.org.au/media-releases/worlds-first-affordable-dialysis-machine-a-finalist-in-2017-eureka-awards (2017).

  • 145.

    Institute for Healthcare Improvement. A patient directs his own care. http://www.ihi.org/resources/Pages/ImprovementStories/APatientDirectsHisOwnCareFarmanSelfDialysis.aspx (2020).

  • 146.

    Shinkman, R. Is “empowered dialysis” the key to better outcomes? NEJM Catalyst Carryover https://doi.org/10.1056/CAT.18.0232 (2018).

    Article 

    Google Scholar
     

  • 147.

    Nayak, K. S., Ronco, C., Karopadi, A. N. & Rosner, M. H. Telemedicine and remote monitoring: supporting the patient on peritoneal dialysis. Perit. Dial. Int. 36, 362–366 (2016).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 148.

    Rohatgi, R., Ross, M. J. & Majoni, S. W. Telenephrology: current perspectives and future directions. Kidney Int. 92, 1328–1333 (2017).

    PubMed 

    Google Scholar
     

  • 149.

    Lew, S. Q. & Sikka, N. Operationalizing telehealth for home dialysis patients in the United States. Am. J. Kidney Dis. 74, 95–100 (2019).

    PubMed 

    Google Scholar
     

  • 150.

    Bieber, S. D. & Gadegbeku, C. A. A call to action for the kidney community: nephrologists’ perspective on advancing American kidney health. Clin. J. Am. Soc. Nephrol. 14, 1799–1801 (2019).

    PubMed 

    Google Scholar
     

  • 151.

    Foundation for EU democracy. Consolidated Reader-Friendly Edition of the Treaty on European Union (TEU) and the Treaty on the Functioning of the European Union (TFEU) as amended by the Treaty of Lisbon (2007) Third edition. http://en.euabc.com/upload/books/lisbon-treaty-3edition.pdf (2009).

  • 152.

    European Kidney Health Alliance. Thematic Network on Improving Organ Donation and Transplantation in the EU 2019. http://ekha.eu/wp-content/uploads/FINAL_Joint-Statement-of-the-Thematic-Network-on-Organ-Donation-and-Transplantation.pdf (2019).

  • 153.

    Massy, Z. A. et al. Nephrology and public policy committee propositions to stimulate research collaboration in adults and children in Europe. Nephrol. Dial. Transpl. 34, 1469–1480 (2019).


    Google Scholar
     

  • 154.

    Beating kidney disease. A joint agenda for research and innovation. https://www.nierstichting.nl/media/filer_public/4d/6d/4d6d6b4e-ce56-4a4b-8ba2-f5ac957d0df8/beating_kidney_disease_-_joint_agenda_for_ri_june_2018.pdf (2018).

  • 155.

    Matesanz, R., Marazuela, R., Coll, E., Mahillo, B. & Dominguez-Gil, B. About the Opt-Out system, live transplantation, and information to the public on organ donation in Spain… Y ole! Am. J. Transpl. 17, 1695–1696 (2017).

    CAS 

    Google Scholar
     

  • 156.

    Zivcic-Cosic, S. et al. Development of the Croatian model of organ donation and transplantation. Croat. Med. J. 54, 65–70 (2013).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Source Link

    Related Posts

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: